Viewing SEC Facts Units
Company Name:
Regulus Therapeutics Inc.
CIK:
1505512
Start Filing Date:
2024-04-01
End Filing Date:
2024-06-30
ACCN:
0001628280-24-036174
Value:
$ 58,000
Value Error:
$ None
Created By:
Date Filed:
2024-08-08
FY:
2024
Fiscal Period:
Q2
Frame:
CY2024Q2
Type:
us-gaap
Form:
10-Q
Units:
USD